The Use of Theory to Develop Physical Activity Interventions in Urological Cancer Survivors: A Narrative Review

Semin Oncol Nurs. 2021 Feb;37(1):151109. doi: 10.1016/j.soncn.2020.151109. Epub 2021 Jan 28.

Abstract

Objectives: To summarize the current available evidence on the use of behavior change theories to explain and change physical activity behavior in urological cancer survivors.

Data sources: Five electronic databases including Medline, Web of Science, Embase, Cochrane, and Psych INFO and reference lists of key studies were searched between database inception and November 2020. Peer-reviewed articles on the use of behavior change theories to understand or change physical activity in urological cancer survivors were included.

Conclusion: The theory of planned behavior and the social cognitive theory were the most used theories to explain and change physical activity behavior in urological cancers, respectively. However, the use of behavior change theories in physical activity interventions for urological cancers is still low across all urological tumor groups. Planning frameworks such as the intervention mapping approach should be used to enhance the systematic use of behavior change theories during every phase of intervention development. In addition, more research is needed to identity which behavior change techniques are most effective to change physical activity behavior in urological cancer survivors.

Implications for nursing practice: Nurses play a key role in the urological cancer patients' clinical pathway and should be able to motivate patients to engage in sufficient physical activity levels. Therefore, it is important that nurses understand the underlying reasons why patients (do not) engage in physical activity and which behavior change techniques are most effective in changing a patients' behavior.

Keywords: Behavior change; Exercise; Intervention mapping; Physical activity; Theory; Urological cancer.

Publication types

  • Review

MeSH terms

  • Cancer Survivors*
  • Exercise
  • Humans
  • Survivors
  • Urologic Neoplasms*